NEW YORK (GenomeWeb News) — The Nasdaq exchange has told Tripos that it will delist its shares from the Global Market on May 30 because it is not in compliance with market rules, Tripos said yesterday.
 
Tripos said it received a letter from the Nasdaq saying the company has failed to maintain the minimum $10 million stockholder equity that the Global Market requires, and because it failed to file its 10-Q quarterly report for the period ended March 31.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.